Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 50 Melanoma 23 Neoplasms 19 Neoplasm Metastasis 19 Squamous Cell Carcinoma of Head and Neck 17 Lung Neoplasms 13 Skin Neoplasms 12 Recurrence 10 Head and Neck Neoplasms 10 Carcinoma, Renal Cell 9 Prostatic Neoplasms 8 Ovarian Neoplasms 8 Colorectal Neoplasms 8 Carcinoma, Squamous Cell 8 Carcinoma, Basal Cell 8 Breast Neoplasms 8 Urinary Bladder Neoplasms 7 Carcinoma, Merkel Cell 7 Triple Negative Breast Neoplasms 6 Colonic Neoplasms 6 Carcinoma 6 Adenocarcinoma 6 Uterine Cervical Neoplasms 5 Sarcoma 5 Pancreatic Neoplasms 5 Glioblastoma 5 Stomach Neoplasms 4 Multiple Myeloma 4 Mouth Neoplasms 4 Fallopian Tube Neoplasms 4

Interventions

cemiplimab 1 Nivolumab 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Cutaneous Squamous Cell Carcinoma (CSCC) × cemiplimab × Clear all

NCT07064330 2025-09-10

NGF-GRACE

Instituto de Investigación Biomédica de Salamanca

Cutaneous Squamous Cell Carcinoma (CSCC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡